Chemo-radiotherapy in Adjuvant Therapy of Curatively Resected Pancreatic Cancer: Lesions from TCOG T3207 Study

被引：5
|
作者：
Chen, Li-Tzong [1 ]
机构：
[1] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan Township, Taiwan
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
10.1093/annonc/mdz354
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DL16
引用
收藏
页码：75 / 75
页数：1
相关论文
共 50 条
  • [21] A Randomized Placebo-Controlled Phase 2 Study of Gemcitabine and Capecitabine with or without T-ChOS as Adjuvant Therapy in Patients with Resected Pancreatic Cancer (CHIPAC)
    Theile, Susann
    Johansen, Julia Sidenius
    Nielsen, Dorte Lisbet
    Jensen, Benny Vittrup
    Hansen, Carsten Palnaes
    Hasselby, Jane Preuss
    Eiriksson, Sverrir Vidalin
    Chen, Inna Markovna
    PHARMACEUTICS, 2022, 14 (03)
  • [22] A phase II trial of gemcitabine and S-1 therapy in patients with resected pancreatic cancer: Japanese study group of adjuvant therapy for pancreatic cancer (JS']JSAP-03)
    Ishii, Hiroshi
    Ueno, Hideki
    Kosuge, Tomoo
    Matsuyama, Yutaka
    Saiura, Akio
    Koga, Rintaro
    Sakamoto, Yoshihiro
    Shimada, Kazuaki
    Nakao, Akimasa
    Doi, Ryuichiro
    Tanaka, Masao
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [23] A phase II trial of gemcitabine and S-1 therapy in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer (JS']JSAP-03)
    Saiura, Akio
    Ueno, Hideki
    Kosuge, Tomoo
    Matsuyama, Yutaka
    Ishii, Hiroshi
    Nakao, Akimasa
    Doi, Ryuichiro
    Tanaka, Masao
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [24] The Impact of Adjuvant Radiation Therapy on Survival in Patients With Surgically Resected Pancreatic Adenocarcinoma: A SEER Study From 2004 to 2010
    Herskovic, A.
    Wu, X.
    Christos, P.
    Ravi, A.
    Nori, D.
    Yan, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E167 - E167
  • [25] Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer (vol 18, pg 1122, 2011)
    Bao, Philip Q.
    Ramanathan, Ramesh K.
    Krasinkas, Alyssa
    Bahary, Nathan
    Lembersky, Barry C.
    Bartlett, David L.
    Hughes, Steven J.
    Lee, Kenneth K.
    Moser, A. James
    Zeh, Herbert J., III
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 : S323 - S323
  • [26] Acute Toxicities From Neoadjuvant Compared to Adjuvant Chemoradiation With the Use of Intensity Modulated Radiation Therapy in Resected Pancreatic Cancer Patients
    Kowalski, E. S. Shea
    Lin, J. Y.
    Choi, E.
    Chuong, M. D.
    Alexander, R.
    Zandberg, D. P.
    Jiang, Y.
    Hanna, N.
    Xu, V.
    Regine, W. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E172 - E173
  • [27] A phase I/II trial of gemcitabine and S-1 therapy in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer (JS']JSAP-03)
    Ishii, H.
    Ueno, H.
    Kosuge, T.
    Matsuyama, Y.
    Saiura, A.
    Nakao, A.
    Doi, R.
    Tanaka, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [28] Randomized, controlled trial comparing S-1 with UFT/LV as adjuvant therapy for curatively resected stage III colorectal cancer (BCOG-CC02 study)
    Koda, Keiji
    Miyauchi, Hideaki
    Yokoi, Kimiyoshi
    Kosugi, Chihiro
    Kaiho, Takashi
    Kobayashi, Susumu
    Ochiai, Takenori
    Matsubara, Hisahiro
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [29] The influence of preoperative chemo-radiotherapy on lymph node yield, N-status and survival in rectal cancer results from a nationwide cohort study
    Lykke, Jakob
    Jess, Per
    Roikjaer, Ole
    APMIS, 2014, 122 : 2 - 3
  • [30] Is there a benefit for adjuvant radio(chemo)therapy in early cervical cancer? Results from a population-based study
    Sophia Scharl
    Cornelia Becher
    Michael Gerken
    Anton Scharl
    Michael Anapolski
    Atanas Ignatov
    Elisabeth C. Inwald
    Olaf Ortmann
    Oliver Kölbl
    Monika Klinkhammer‑Schalke
    Thomas Papathemelis
    Archives of Gynecology and Obstetrics, 2021, 304 : 759 - 771
12345